A Study to Investigate the Safety and Tolerability of a New Inhaled Formulation of RV568 in Healthy Volunteers

NCT01661244 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

COPD
Healthy Volunteers

Interventions

DRUG: RV568 single dose
DRUG: RV568 matching placebo single dose
DRUG: RV568 repeat dose
DRUG: RV568 matching placebo repeat dose

Sponsor

Respivert Ltd